美女免费一级视频在线观看

    • <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      Los Angeles Chargers head coach Jim Harbaugh doesn’t mess around — especially when it comes to healthcare. 
      




      That’s why Harbaugh partnered with antibody biotech Invivyd this week to raise awareness about the potential short- and long-term risks of COVID-19.
      




      As part of the effort, both Harbaugh and Invivyd want patients to know their treatment options nearly five years after the pandemic began.
      




      Though no longer the pressing public health threat it once was, COVID maintains a worrisome presence in multiple patient populations. Last year, the disease caused approximately 59,000 deaths and more than 500,000 hospitalizations in the U.S.. 
      




      More specifically, this partnership focuses on “long COVID,” a term coined by the scientific community to describe the long-term effects of the virus.
      




      While not fully understood from a clinical perspective, it is still regarded as a serious issue despite the availability and advancements of vaccine boosters. A recently published article from the Journal of Infectious Diseases suggested the long-term health and economic impacts of the disease may have already exceeded several other chronic diseases. 
      




      Additionally, the percentage of COVID-associated hospitalizations with intensive care unit (ICU) admissions is once again on the rise — though they still pale in comparison to the record highs from 2020 through 2022.
      




      With this sticky challenge in mind, Invivyd, a biopharmaceutical company devoted to creating therapies against serious viral infectious diseases, is working with Harbaugh on various live and social media initiatives to raise awareness about the issue. 
      




        
       
       
       
       
       
       
      View this post on Instagram
       
       
       
       
       
       
       
       
       
       
       
       
      A post shared by Invivyd (@invivyd)
      





      Harbaugh expressed his enthusiasm for the collaboration, underscoring his commitment to maintaining healthy futures for people on and off the field. 
      




      “As a long-time coach, I want players on the field, fans in the stands, and friends and family gathering to enjoy the game. But, COVID-19 has and continues to sideline many people,” Harbaugh said in a statement. 
      




      He added that while COVID may seem like old news to some, many Americans continue to get sick, are hospitalized and are dying from COVID, despite being vaccinated. 
      




      “The extent of damage to our bodies in the long-term is still unknown,” he stated. 
      




      The coach also emphasized resources beyond the well-known vaccines on the market, encouraging patients to visit expandtheiroptions.com to learn more about resources to tackle long COVID.
      




      The partnership was announced at a fitting time: the week prior to the Super Bowl, which is estimated to draw more than 110 million views this year. 
      




      The Invivyd team echoed Harbaugh’s ambition to raise awareness about the issue, emphasizing the need for expanding education around the disease for all. 
      




      “We are thrilled to have Coach Harbaugh on our team as we work to educate healthcare providers as well as the millions of immunocompromised people we serve about the continued prevalence and significant risks of COVID-19, which is common, but not a cold,” noted Julie Green, Invivyd’s chief human resources officer and head of communications, in a statement.